Results 191 to 200 of about 65,459 (255)

Distinction Between Proliferative Lupus Nephritis and Membranous Lupus Nephritis Based on Inflammation, NETosis, and Glomerular Exostosin. [PDF]

Int J Mol Sci
Wada Y, Okawa H, Abe T, Takeuchi K, Kamata M, Takeuchi E, Suenaga T, Iyoda M, Takeuchi Y.   +8 more
europepmc   +1 more source

Refractory lupus nephritis: current Understanding and emerging treatment strategies. [PDF]

Clin Exp Med
Ding T, Fan Y, Zhang X, Zhang Z.
europepmc   +1 more source

Association between the CRP-TyG index and lupus nephritis risk. [PDF]

Biomol Biomed
Liang B, Tang M, Huang J, Li Y, Liang R, Zhai Z, Sun E.   +6 more
europepmc   +1 more source

The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients With Lupus Nephritis. [PDF]

J Rheumatol
O'Connor SK, Devarajan P, Liu J, Maldonado MA, Sproles A, Rose J, Thornton S, Chen C, Huang B, Brunner HI.   +9 more
europepmc   +1 more source

PHLDB1 and WDFY4 as dual-state biomarkers in SLE pathogenesis and lupus nephritis prediction. [PDF]

BMC Immunol
Zhai J, Zhang L, Jia W, Pan Y, Zhang P, Zou Q, Wu Y.   +6 more
europepmc   +1 more source

Comment on: "Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study". [PDF]

Rheumatol Immunol Res
Bakay U.
europepmc   +1 more source

Lupus nephritis outcomes in Aotearoa New Zealand, a retrospective case series. [PDF]

Lupus
Bowman J, White D, Lao C, Gregory K, Kenwright D, Chembo C, Clark C, Grainger R.   +7 more
europepmc   +1 more source

Iron metabolism and ferroptosis: druggable targets to delay the progression of lupus nephritis. [PDF]

Am J Physiol Renal Physiol
Al-Hraki L, Morel L, Scindia Y.
europepmc   +1 more source

Evolution of idiopathic membranous nephropathy to class v lupus nephritis: a case report and literature review. [PDF]

Front Med (Lausanne)
Shen B, Peng C, Xiao W.
europepmc   +1 more source